Global CBD markets are under pressure after the European Commission (EC) asserted that CBD extracts from hemp flowers aren’t valid for approval under the Novel Foods policy. A spokesperson for the EC said primary concern lies with “CBD extracted from the flowering and fruiting tops of the hemp plant (Cannabis sativa)”. The European Commission has “informed the applicants of its preliminary views and invited them to provide comments”, the spokesperson added. This includes 50 applicants from a number of countries, including the US.
Czech based CBDepot submitted their application for synthetic CBD to the European Food Safety Authority (EFSA) in November of last year. On March 31, CBDepot’s application for registering synthesized trans-CBD as a ‘Novel Food’ substance appeared as EC Mandate# M-2018-0021 on EFSA’s Register of Questions portal:
…
11.15.2024
October soybean crush reaches all-time monthly high; biofuel demand limits rise in soybean oil stocks
The National Oilseed Processors Association (NOPA) reported the October soybean crush at a record monthly high of 199.9592 million bushels, eclipsing the previous record of 196.406 million bushels set...
11.15.2024
UCO 2025 market clouded by China’s cancellation of export rebate
China will cancel its current 13% export tax rebate for used cooking oil (UCO), a key biofuel feedstock, effective December 1, the country’s Ministry of Finance and the State...
11.15.2024
US animal protein prices steady to firmer week on week; SBM under pressure
The US animal proteins market was steady to higher in the week to Friday November 15. Even with decreases in Chicago Board of Trade (CBOT) soybean meal futures, prices...